We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
-0.69%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$67.5B
AUM Growth
+$10.9B
Cap. Flow
+$12.7B
Cap. Flow %
18.75%
Top 10 Hldgs %
49.27%
Holding
2,060
New
26
Increased
289
Reduced
1,527
Closed
195

Top Sells

1
NVDA icon
NVIDIA
NVDA
+$799M
2
AAPL icon
Apple
AAPL
+$563M
3
MSFT icon
Microsoft
MSFT
+$445M
4
AMZN icon
Amazon
AMZN
+$321M
5
AVGO icon
Broadcom
AVGO
+$274M

Sector Composition

1 Technology 23.92%
2 Consumer Staples 7.59%
3 Consumer Discretionary 6.94%
4 Communication Services 6.66%
5 Industrials 6.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRTA
1801
Strata Critical Medical Inc
SRTA
$453M
$42K ﹤0.01%
10,040
-2,439
-20% -$11.7K
OLPX
1802
DELISTED
Olaplex Holdings
OLPX
$41.3K ﹤0.01%
20,367
-5,391
-21% -$8.27K
HNST icon
1803
The Honest Company
HNST
$432M
$40.4K ﹤0.01%
13,729
-3,334
-20% -$8.58K
ALIT icon
1804
Alight
ALIT
$568M
$39.3K ﹤0.01%
3,368
-574
-15% -$13.7K
LAB icon
1805
Standard BioTools
LAB
$336M
$38.3K ﹤0.01%
41,674
-13,034
-24% -$15.8K
ACCO icon
1806
Acco Brands
ACCO
$386M
$38K ﹤0.01%
12,670
-3,302
-21% -$12.4K
DNUT icon
1807
Krispy Kreme
DNUT
$588M
$37.9K ﹤0.01%
11,184
-2,852
-20% -$9.84K
EVH icon
1808
Evolent Health
EVH
$638M
$36.9K ﹤0.01%
16,174
-5,275
-25% -$16.7K
CHRS icon
1809
Coherus Oncology
CHRS
$214M
$36.7K ﹤0.01%
21,700
-3,018
-12% -$5.36K
TOI icon
1810
The Oncology Institute
TOI
$526M
$35.5K ﹤0.01%
11,561
-908
-7% -$2.78K
OABI icon
1811
OmniAb
OABI
$296M
$35.4K ﹤0.01%
22,552
-3,024
-12% -$5.46K
EVEX icon
1812
Eve Holding
EVEX
$777M
$34.5K ﹤0.01%
13,898
-3,624
-21% -$12.4K
RC
1813
Ready Capital
RC
$271M
$34.4K ﹤0.01%
21,230
-5,894
-22% -$11.3K
HLLY icon
1814
Holley
HLLY
$335M
$34K ﹤0.01%
11,076
-2,885
-21% -$10.9K
BMBL icon
1815
Bumble
BMBL
$395M
$34K ﹤0.01%
10,426
-2,878
-22% -$9.57K
ELDN icon
1816
Eledon Pharmaceuticals
ELDN
$296M
$33.4K ﹤0.01%
10,832
+566
+6% +$1.33K
EGHT icon
1817
8x8 Inc
EGHT
$288M
$33K ﹤0.01%
19,903
-4,544
-19% -$9.3K
EVGO icon
1818
EVgo
EVGO
$244M
$32.4K ﹤0.01%
18,815
-4,615
-20% -$12.3K
MVIS icon
1819
Microvision
MVIS
$104M
$32.3K ﹤0.01%
50,367
-10,898
-18% -$8.31K
RZLT icon
1820
Rezolute
RZLT
$421M
$32K ﹤0.01%
10,494
-4,263
-29% -$12.8K
CMTG icon
1821
Claros Mortgage Trust
CMTG
$325M
$31.9K ﹤0.01%
13,383
-3,485
-21% -$9.03K
HYLN icon
1822
Hyliion Holdings
HYLN
$667M
$31.6K ﹤0.01%
17,971
-4,681
-21% -$9.42K
POWW icon
1823
Outdoor Holding Co
POWW
$271M
$30.9K ﹤0.01%
15,351
-496
-3% -$944
SVC
1824
Service Properties Trust
SVC
$1.13B
$30.8K ﹤0.01%
4,549
-1,101
-19% -$11.5K
OSUR icon
1825
OraSure Technologies
OSUR
$273M
$30.3K ﹤0.01%
10,090
-2,876
-22% -$8.19K

Similar funds

ProShare Advisors's Q1 2026 Portfolio in Review

As of Q1 2026, ProShare Advisors held 2,060 positions worth $67.5B, up 19% from $56.7B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

ProShare Advisors deployed $12.7B of net new capital in Q1 2026, opening 26 new positions and adding to 289 existing holdings. Its largest new stake was ProShares GENIUS Money Market ETF: 197,028,347 shares worth $19.7B.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 37% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was NVIDIA, an estimated $799M trimmed.

  • ProShare Advisors's largest Q1 2026 buy was ProShares GENIUS Money Market ETF: 197,028,347 shares worth $19.7B.
  • ProShare Advisors added most to Walmart Inc in Q1 2026, an estimated $729M increase.
  • ProShare Advisors's biggest Q1 2026 reduction was NVIDIA, cutting an estimated $799M.
  • ProShare Advisors fully exited AstraZeneca in Q1 2026, selling an estimated $85.7M.
  • ProShare Advisors's ten largest holdings make up 49% of its $67.5B portfolio in Q1 2026.
  • ProShare Advisors opened 26 new positions and closed 195 in Q1 2026.
  • ProShare Advisors's portfolio value rose 19% quarter-over-quarter to $67.5B.

Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.